NIH Office of Rare Diseases Research (ORDR)

Text Size: A A A

U.S. Department of Health & Human Services

ORDR co-sponsored Scientific Conferences

Conference Search
Upcoming Conferences
ORDR Home
Contact Us
Chris Griffin
Program Analyst
Office of Rare Diseases Research
National Center for Advancing Translational Sciences (NCATS)
National Institutes of Health
6701 Democracy Boulevard
Suite 1001, MSC 4874
Bethesda, MD 20892
(P): (301) 496-0266
(F): (301) 480-9655
E-mail:griffinc@od.nih.gov

Co-funding Institute(s): National Institute of Neurological Disorders and Stroke (NINDS)
Office of Rare Diseases Research (ORDR)

Drug Discovery in ALS: Opportunities and Challenges
March 4, 2012 - March 7, 2012
Washington, D.C., United States

Description
The goals of the workshop are: [1] To bring clinical and scientific leaders from academia and industry together to focus on drug discovery for ALS. [2] To enable discussion and new project ideas to evolve from the interaction of researchers with different expertise in ALS and related fields. [3] To bring young researchers at an early stage of their careers to a stimulating and educational forum enabling them to interact and learn from their peers. [4] To discuss three key areas that impact ALS Drug Discovery and related fields: A) Academic and Industry Partnerships, B) New Opportunities for Biomarker studies in ALS, and C) Clinical Trials Networks to enhance patient enrollment and standardization of trials between sites.

Contact for additional information: Dr. Margaret Sutherland, 301-496-5680

Additional Information:

Note: If you need help accessing information in different file formats such as PDF, MP3, see Viewers, Players, and Plug-ins.